<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370712</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3660</journal-id>
<journal-id journal-id-type="nlm-ta">Exp Neurol</journal-id>
<journal-id journal-id-type="iso-abbrev">Exp. Neurol.</journal-id>
<journal-title-group>
<journal-title>Experimental neurology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0014-4886</issn>
<issn pub-type="epub">1090-2430</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28373025</article-id>
<article-id pub-id-type="pmc">5538963</article-id>
<article-id pub-id-type="doi">10.1016/j.expneurol.2017.03.026</article-id>
<article-id pub-id-type="manuscript">NIHMS870271</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Early-life febrile seizures worsen adult phenotypes in <italic>Scn1a</italic> mutants</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dutton</surname>
<given-names>Stacey B. B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dutt</surname>
<given-names>Karoni</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Papale</surname>
<given-names>Ligia A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Helmers</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goldin</surname>
<given-names>Alan L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Escayg</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Human Genetics, Emory University, Atlanta, GA, 30022</aff>
<aff id="A2">
<label>2</label>Departments of Microbiology &amp; Molecular Genetics and Anatomy &amp; Neurobiology, University of California, Irvine, CA, 92697</aff>
<aff id="A3">
<label>3</label>Department of Neurology, Emory University, Atlanta, GA, 30022</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Andrew Escayg, Ph.D. Emory University, Department of Human Genetics, 615 Michael Street, Whitehead Building, Suite 301, Atlanta, Georgia 30322, USA, Telephone number: (404) 712-8328, Fax number: (404) 727-3949, <email>aescayg@emory.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>13</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>7</month>
<year>2018</year>
</pub-date>
<volume>293</volume>
<fpage>159</fpage>
<lpage>171</lpage>
<!--elocation-id from pubmed: 10.1016/j.expneurol.2017.03.026-->
<abstract>
<p id="P1">Mutations in the voltage-gated sodium channel (VGSC) gene <italic>SCN1A</italic>, encoding the Na<sub>v</sub>1.1 channel, are responsible for a number of epilepsy disorders including genetic epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS). Patients with <italic>SCN1A</italic> mutations often experience prolonged early-life febrile seizures (FSs), raising the possibility that these events may influence epileptogenesis and lead to more severe adult phenotypes. To test this hypothesis, we subjected 21-23-day-old mice expressing the human <italic>SCN1A</italic> GEFS+ mutation R1648H to prolonged hyperthermia, and then examined seizure and behavioral phenotypes during adulthood. We found that early-life FSs resulted in lower latencies to induced seizures, increased severity of spontaneous seizures, hyperactivity, and impairments in social behavior and recognition memory during adulthood. Biophysical analysis of brain slice preparations revealed an increase in epileptiform activity in CA3 pyramidal neurons along with increased action potential firing, providing a mechanistic basis for the observed worsening of adult phenotypes. These findings demonstrate the long-term negative impact of early-life FSs on disease outcomes. This has important implications for the clinical management of this patient population and highlights the need for therapeutic interventions that could ameliorate disease progression.</p>
</abstract>
<kwd-group>
<kwd>Febrile seizures</kwd>
<kwd>GEFS+</kwd>
<kwd>
<italic>SCN1A</italic>
</kwd>
<kwd>Epilepsy</kwd>
<kwd>Na<sub>v</sub>1.1</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>